Society of Toxicology 2021 Virtual Conference
With our collective experience of over 400 years in drug discovery and development, we have the expertise to design a high quality, cost-effective nonclinical safety package that perfectly aligns with your project.
For more information download our brochure here
Watch our recent webinar, part of the Medicines Discovery Catapult Connects series of webinars “Is My Compound Safe?”. This webinar was recorded at the same time as “How to get your molecule into Humans” presented by Pauline Garner of Sequani. MDC has written up a summary of each presentation from the webinars, creating a great resource of modern drug discovery knowledge. Download here. (This video has closed captions – if you would like to see these just click on “CC” on the control panel).
Meet Dr Richard Knight, Director and Co-founder
“A co-founder of ApconiX, Richard is an expert toxicologist with more than 20 years of drug development experience gained in AstraZeneca, where he was part of the Drug Safety and Oncology Leadership Teams. Richard has worked on projects in multiple therapy areas involving small molecules, biologics, proteins and oligonucleotides. He has an in-depth understanding of drug discovery and drug development and has been directly involved in bringing over 35 new candidate drugs to clinical trials and 6 to marketing approval. He uses his extensive experience to bring an innovative, science-led and pragmatic approach to the design and delivery of nonclinical safety programmes.”